Posts

Facebook Marketplace is home to steals and deals—and se...

Love it or hate it, Facebook Marketplace is the largest online resale site today...

Eco-friendly and affordable battery for low-income coun...

A battery made from zinc and lignin that can be used over 8000 times. This has b...

New transit station in Japan significantly reduced cumu...

The declining population in Osaka is related to an aging society that is driving...

5 Fatalities in MacroGenic’s ADC Trial

MacroGenics’s safety concerns have continued throughout phase 2 of the project. ...

The Keytruda regimen study by Merck fails to reach its ...

The Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) research study, which aimed to t...

Pfizer and AstraZeneca unveil plans for almost $1B of n...

As France prepares for its annual ‘Choose France’ business summit, the pharmaceu...

Triomics to attempt to revolutionize clinical trials fo...

Founded by two college friends, Hrituraj Singh and Sarim Khan, Triomics is an ar...

Lula’s progress plan for Brazil: A year on

Almost 12 months after the South American Summit, advancing pharma trade and rai...

CSUFT-led team creates novel flame-retardant, smoke-sup...

Professors Yiqiang Wu and Caichao Wan, along with their team from Central South ...

An auxiliary CHD diagnostic system based on multi-view ...

Congenital heart disease (CHD) is one of the most common congenital anomalies wo...

KITECH develops deformable energy storage device via la...

The joint research team, led by Dr. Chanwoo Yang and Researcher Seong Ju Park fr...

Shionogi secures licence for Maze’s Pompe disease treat...

Shionogi has concluded an exclusive global licence agreement for Maze Therapeuti...

Formosa and Tabuk sign deal for FDA-approved ophthalmic...

Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmi...

Four ways the vaccine rush will define infectious disea...

GlobalData examines four of the key trends affecting contract research organizat...

Attovia secures $105m to advance development of lead pr...

Attovia Therapeutics has secured $105m in a Series B financing round to expedite...

Novo Nordisk enters deal to develop obesity therapy

Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biot...